Karuna Therapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
10/10
|
0.16 | -268.1 | -100.06% | -13.4 | -101.19% |
| P/S |
|
17914.4 | 55.96 | 31914.45% |
|
|
| P/BV |
|
9.34 | 251.23 | -96.28% |
|
|
| P/FCF |
|
-16.77 | -196.64 | -91.47% |
|
|
| Ev/Ebitda |
|
-23.42 | 12.23 | -291.42% |
|
|
| Ev/S |
|
17655.79 | 457.86 | 3756.15% |
|
|
| Ev/FCF |
|
-29.7 | -232.19 | -87.21% |
|
|
| E/P |
|
-0.0665 | 0.0224 | -397.35% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-75393.88 | -341.3 | 21990.33% | -30777.57 | +144.96% |
| ROE |
|
-34.58 | 103.63 | -133.36% |
|
|
| ROA |
|
-32.46 | -2.84 | 1043.6% |
|
|
| ROIC |
|
-32.8 | 1.17 | -2894% |
|
|
| ROS |
|
-66311.93 | -298.77 | 22095.11% |
|
|
| ROCE |
|
-39.45 | -0.0718 | 54844.61% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0338 | 0.9431 | -103.59% | -0.0345 | -1.82% |
| Nеt Debt/Ebitda |
|
0.343 | 1.03 | -66.54% |
|
|
| Debt/Ratio |
|
0.0125 | 0.1785 | -93% |
|
|
| Debt/Equity |
|
0.0654 | 1.56 | -95.8% |
|
|
| Debt/Net Income |
|
-0.0385 | -1.48 | -97.4% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5195 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.8444 | -100% | ||
| DSI |
|
0 | 0.2147 | -100% |
|
|
| Average dividend growth |
|
0 | 1.27 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.5087 | -100% |
|
|
| Average percentage for payments |
|
0 | 59.63 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5195 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-98.23 | -87.95 | 11.69% | ||
| Growth impulse Ebitda in 5 years |
|
1049.36 | -156.19 | -771.85% | ||
| Growth impulse Net Income in 5 years |
|
885.64 | -172.49 | -613.44% | ||
| Growth impulse FCF in 5 years |
|
1153.99 | -114.74 | -1105.74% | ||
| Growth impulse EPS in 5 years |
|
218.86 | -98.04 | -323.24% |
IP Score
4.23/10
